Telix Pharmaceuticals and Ekalia have teamed up to establish U.S.-based production of astatine-211, a rare alpha-emitting isotope used in targeted alpha therapy for cancer. This collaboration combines IBA's cyclotron technology, Framatome's nuclear expertise, and Telix's manufacturing and clinical capabilities to ensure a reliable supply of astatine-211. The first production unit will be installed near Philadelphia, with plans to expand as demand grows. This initiative supports Telix's cancer therapy pipeline and broadens access for academic and industry research in the U.S.
Telix and Ekalia's collaboration on astatine-211 production is the story's focus, with Pluang data showing 81 of 150 Health-sector US stocks rose while 66 fell as of Oct 19, 2026 12:01 WIB. Notable movers include ERAS at USD 13.39 with a -8.91% change and a typical hold time of 2 days, BNGO at USD 1.25 down 8.76% with a 50-day hold, and MESO at USD 12.69 down 7.98% with a 16-day hold. This snapshot provides a view of market activity in related health stocks on Pluang's platform.
At ESMO 2026, Roche presented key Phase III trial results showcasing significant advances in cancer treatment. Divarasib demonstrated superior efficacy over first-generation KRAS G12C inhibitors in advanced lung cancer, potentially setting a new stan...
Red Cat Holdings announced a voluntary public purchase offer to acquire all outstanding shares of Steyr Motors AG at €39 per share in cash, representing a significant premium over recent prices. The acquisition aims to strengthen Red Cat's Blue Ops u...
Hayati®, a UK-based technology and vaping brand, partnered with elrow at the Edinburgh Festival to launch the "TURN UP WITH HAYATI®" activation. This collaboration featured a dedicated space with interactive activities, special festival edition produ...
Commvault Systems is recommended as a buy due to its strong SaaS annual recurring revenue growth of 38% and decade-high profit margins. The stock is currently undervalued, trading at 27 times estimated earnings for fiscal year 2027 and 24 times for 2...
Wormhole (W) has fallen about 10% recently, driven mainly by large investors (whales) selling on OKX, while Binance whales are accumulating. The Funding Rate shows reduced bearish pressure, improving from -0.0484% to -0.0083%, indicating a gradual bu...
